- Home
- INMB vs SGMO Comparison
INMB vs SGMO Comparison
Compare INMB & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INMB
- SGMO
- Stock Information
- Founded
- INMB 2015
- SGMO 1995
- Country
- INMB United States
- SGMO United States
- Employees
- INMB N/A
- SGMO N/A
- Industry
- INMB Biotechnology: Pharmaceutical Preparations
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INMB Health Care
- SGMO Health Care
- Exchange
- INMB Nasdaq
- SGMO Nasdaq
- Market Cap
- INMB 176.5M
- SGMO N/A
- IPO Year
- INMB 2019
- SGMO 2000
- Fundamental
- Price
- INMB $7.09
- SGMO $0.72
- Analyst Decision
- INMB Strong Buy
- SGMO Buy
- Analyst Count
- INMB 3
- SGMO 6
- Target Price
- INMB $24.33
- SGMO $5.17
- AVG Volume (30 Days)
- INMB 225.9K
- SGMO 4.5M
- Earning Date
- INMB 05-08-2025
- SGMO 05-20-2025
- Dividend Yield
- INMB N/A
- SGMO N/A
- EPS Growth
- INMB N/A
- SGMO N/A
- EPS
- INMB N/A
- SGMO N/A
- Revenue
- INMB $14,000.00
- SGMO $57,800,000.00
- Revenue This Year
- INMB N/A
- SGMO N/A
- Revenue Next Year
- INMB N/A
- SGMO $15.47
- P/E Ratio
- INMB N/A
- SGMO N/A
- Revenue Growth
- INMB N/A
- SGMO N/A
- 52 Week Low
- INMB $4.32
- SGMO $0.30
- 52 Week High
- INMB $11.76
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- INMB 41.97
- SGMO 47.74
- Support Level
- INMB $6.98
- SGMO $0.52
- Resistance Level
- INMB $8.00
- SGMO $0.79
- Average True Range (ATR)
- INMB 0.45
- SGMO 0.08
- MACD
- INMB -0.06
- SGMO -0.00
- Stochastic Oscillator
- INMB 6.51
- SGMO 62.44
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.